protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …

pharmaceutical trade data from 1996 to 2005, we examine the role of China and India as suppliers of medicines to other middle- and … medicines from high- income countries. We find that imports of antibiotics and unspecified medicaments from India and China … significantly depress the average price of these commodities imported from high-income trading partners, suggesting that India and …

relative magnitudes of the two sources of competition in limiting innovative returns in the U.S. pharmaceuticals market. In …

pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine …In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for … pharmaceutical product sales data for India with a newly gathered dataset of molecule-linked patents issued by the Indian patent …

discusses the various theoretical implications for a developing country of introducing product patents for pharmaceuticals …. Using India as an example, it then brings together information gathered from both published sources and personal interviews …

countries with restrictions on secondary patents, India, Brazil, and Argentina. We examine cross-country comparisons of primary …

tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …